IP Library Granted Patent US 7,811,222
Granted Patent B2
US 7,811,222 · App. 11/518,932 · Granted Oct 12, 2010

Method and apparatus for treating pelvic organ prolapse

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,811,222
App. No.
11/518,932
Granted
Oct 12, 2010
Kind
B2
Abstract

An apparatus for treating pelvic organ prolapse in a patent is provided. The apparatus includes a support portion having first and second ends. A first elongated end portion is connected to the first end of the support portion. The first elongated end portion includes a first dilator configured to attach securely with a tip of a needle. A second elongated end portion is connected to the second end of the support portion. The second elongated end portion includes a second dilator configured to attach securely with a tip of a needle. The first and second needles include a straight portion, a tip, a first radius, and a second radius distinct from the first radius. The first radius and the second radius are disposed between the straight portion and the tip. A method and kit for the treatment is further provided.

Claims (28)

1. An apparatus for treating pelvic organ prolapse in a patient utilizing a posterior perirectal tissue pathway comprising:

a support portion adapted to be placed in a therapeutically effective position, including first and second ends;

a first elongated end portion connected to said first end of said support portion, wherein the first elongated end portion includes a first dilator configured to attach securely with a tip of a needle;

a second elongated end portion connected to said second end of said support portion, wherein the second elongated end portion includes a second dilator configured to attach securely with a tip of a needle;

a first needle including a straight portion, a tip, and a curved portion between the straight portion and the tip, the curved portion having a first radius of curvature, and a second radius of curvature distinct from the first radius of curvature, wherein the first radius of curvature of the first needle is between the tip of the first needle and the second radius of curvature of the first needle, and the first radius of curvature of the first needle is between about 2 inches and about 4 inches and the second radius of curvature of the first needle is between about 4 inches and about 6 inches.

2. The apparatus of claim 1 , further comprising:

a second needle comprising a straight portion, a tip, and a curved portion between the straight portion and the tip, the curved portion having a first radius of curvature, and a second radius of curvature distinct from the first radius of curvature, wherein the first radius of curvature is between the tip of the second needle and the second radius of curvature of the second needle, and the first radius of curvature is between about 2 inches and about 4 inches and the second radius of curvature is between about 4 inches and about 6 inches.

3. The apparatus of claim 2 , wherein the straight section of the first needle is between about 5 inches and about 7 inches.

4. The apparatus of claim 3 , wherein the straight section of the first needle is between about 5.5 inches and about 6.5 inches.

5. The apparatus of claim 3 , wherein the straight section of the first needle is between about 4.5 inches and about 5.5 inches.

6. The apparatus of claim 2 , further comprising a tool for connecting the tip of the first needle to the dilator of the first elongated portion.

7. The apparatus of claim 2 , further comprising:

a first transition zone disposed between the first elongated end portion and the first dilator; and,

a second transition zone disposed between the second elongated portion and the second dilator,

wherein the first transition zone and the second transition zone are each comprised of a riveted synthetic cape which provides a tapered transition from respective end portion to dilator.

8. The apparatus of claim 1 , further comprising a repositioning means to effect tightening or loosening said apparatus without adversely affecting the therapeutic efficacy of said apparatus.

9. The apparatus in claim 8 , wherein said repositioning means comprises at least one filament threaded along at least one end portion.

10. The apparatus of claim 1 , wherein the diameter of said first needle is between about 0.100 inches and about 0.150 inches.

11. The apparatus of claim 1 , wherein the straight section of the first needle is between about 3 inches and about 7 inches.

12. A kit for repairing pelvic organ prolapse in a patient utilizing a posterior perirectal tissue pathway comprising:

a support member comprising a support portion and two end portions, wherein at least one of said end portions further comprises a removable plastic sheath;

a first needle comprising a first handle, a first tip, a straight portion, and a curved portion between the straight portion and the tip, the curved portion having a first radius of curvature, and a second radius of curvature different from the first radius of curvature, wherein the first radius of curvature of the first needle is between the tip of the first needle and the second radius of curvature of the first needle, and the first radius of curvature of the first needle is between about 2 inches and about 4 inches and the second radius of curvature of the first needle is between about 4 inches and about 6 inches, and the first needle is configured to form a first pathway through tissue adjacent to said prolapsed organ, said pathway extending between an external perirectal region and a region of an ischial spine of the patient.

13. The kit of claim 12 , further comprising:

a second needle comprising a second handle, a second tip, a straight portion, and a curved portion between the straight portion and the tip, the curved portion having a first radius of curvature, and a second radius of curvature different from the first radius of curvature, wherein the first radius of curvature of the second needle is between the tip of the second needle and the second radius of curvature of the second needle, and the first radius of curvature of the second needle is between about 2 inches and about 4 inches and the second radius of curvature of the second needle is between about 4 inches and about 6 inches, and the second needle is configured to form a second pathway through tissue adjacent to said prolapsed organ, said pathway extending between an external perirectal region and a region of an ischial spine of the patient.

14. The kit of claim 13 , wherein the first radius of curvature of the first needle is located on the same side of the first needle as the second radius of curvature.

15. The kit of claim 14 , wherein the first radius of curvature of the second needle is located on the same side of the second needle as the second radius of curvature.

16. The kit of claim 13 , wherein the first radius of curvature of the first needle is located on the opposite side of the first needle from the second radius of curvature.

17. The kit of claim 16 , wherein the first radius of curvature of the second needle is located on the opposite side of the second needle from the second radius of curvature.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043780/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043778/0302 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →